Today, our scientists and doctors are transforming cancer care through precision immuno-oncology — tailoring immunotherapy treatments to the unique biology of each patient's cancer. At MSK, ...
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTX) (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT ...
New research from Memorial Sloan Kettering Cancer Center (MSK) finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results